Thailand-based healthcare company Mega Lifesciences recently announced its foray into the Indian market with the launch of its oral consumption skincare range and said it will invest about USD 1 million to market the product in the country. The company would be undertaking marketing and distribution of its brands ‘Glow’ and ‘Pynocare’ and would initially focus on the National Capital Region, before expanding the reach to other cities across India, Mega Lifesciences Regional Director Sudhir Gandhi told reporters here. The products, both for men and women, would be available at all pharma outlets in the NCR. The company would import the products from its manufacturing units in Bangkok and Melbourne. and would consider setting up a manufacturing plant in India depending on the sale of the products.